Download presentation
Presentation is loading. Please wait.
Published byOldwig Bösch Modified over 6 years ago
1
Managing PAD with multiple platelet inhibitors: the effect of combination therapy on bleeding time
Douglas B Wilhite, MD, Anthony J Comerota, MD, Frank A Schmieder, MD, Richard C Throm, BA, John P Gaughan, PhD, A Koneti Rao, MD Journal of Vascular Surgery Volume 38, Issue 4, Pages (October 2003) DOI: /S (03)
2
Fig 1 Outline of treatment program. Each treatment phase lasted for 14 days, with an initial washout period, during which the patient took no platelet-inhibiting medications. Washout was repeated throughout the protocol as necessary in order to prevent carryover of drug effects. Journal of Vascular Surgery , DOI: ( /S (03) )
3
Fig 2 Average bleeding time for each treatment phase. Error bars demonstrate SE. Base, Baseline BT; ASA, aspirin 325 mg QD; Clop, clopidogrel 75 mg QD; Cilo, cilostazol, 100 mg BID. *P ≤ .05 versus baseline. **P ≤ .05 versus all single agents and versus ASA + Cilo and Clop + Cilo. Journal of Vascular Surgery , DOI: ( /S (03) )
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.